← Back to homeNovo Nordisk Raises Its 2026 Forecast for a Third Time
A pill that reached pharmacies in January is now carrying far more of the Danish drugmaker's year than analysts had counted on.
Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources Brief
Novo Nordisk lifted its full-year forecast a third time on Wednesday, Nov. 4, after sales of its new Wegovy pill landed well above what analysts…
More reporting and context continue here.
The complete story is available with Premium.
Read the facts, open questions and supporting sources.
Continue reading with NewsPlain Premium.
Keep reading with NewsPlain Premium
Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.
3 sources behind this story.
By NewsPlain Editorial Team · Published
About this story
We haven’t published a correction to this story.
How NewsPlain works ← Back to home